Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/01/2003WO2001098346A3 Methods and compositions for the treatment of peripheral artery disease
05/01/2003WO2001080891A8 Remedies for interstitial pneumonia, method of constructing animal model of this disease and screening method with the use of the same
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084484 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/01/2003US20030084471 Methods and compositions for RNA interference
05/01/2003US20030084465 Animal is sensitized to selected antigen by administering antigen or nucleic acid encoding antigen; preferred antigens are anaphylactic antigens; sensitized animal can be used to screen for compounds which may help to cure allergies
05/01/2003US20030084464 Methods of detecting genetic alterations associated with abdominal wall defects; gastroschisis
05/01/2003US20030083739 For treating vascular in-stent restenosis; drug delivery
05/01/2003US20030083642 Devices and methods for the restoration of a spinal disc
05/01/2003US20030083486 Physiologically active protein originating in mammals
05/01/2003US20030083484 Antisense modulation of short heterodimer partner-1 expression
05/01/2003US20030083482 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation disorders
05/01/2003US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer
05/01/2003US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083478 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular, fertility, contraceptive and urogenital disorders
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083471 Method for purification of proteins
05/01/2003US20030083470 Polypeptide for use in controlling gene transcription and treating cancer
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083465 Protein for use in treatment and prevention of angiogenesis
05/01/2003US20030083463 Novel proteins and nucleic acids encoding same
05/01/2003US20030083462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083369 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
05/01/2003US20030083339 Using antagonists of the Angiotensin II type 2 receptor (AT2 receptor) for example candesartan cilexetil; combination treatment with an ACE inhibitor (angiotensin converting enzyme=ACE); drug screening assays
05/01/2003US20030083313 Means of tumor therapy
05/01/2003US20030083308 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses
05/01/2003US20030083304 CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
05/01/2003US20030083303 A replicated and packaged vector construct inside a virion particle in the helper cell, able expressing a foreign gene in a mammalian cell; use in transfection
05/01/2003US20030083302 An oligonucleotides are specifically hybridizable with targeted nucleic acids to inhibit the gene expression of DNA helicases
05/01/2003US20030083301 Therapeutic treatments for spinal cord injury via blockade of interleukin-1 receptor
05/01/2003US20030083300 Antisense modulation of cellular inhibitor of Apoptosis-2 expression
05/01/2003US20030083299 Non-invasive delivery of polypeptides through the blood-brain barrier
05/01/2003US20030083296 Antisense modulation of caspase 8 expression
05/01/2003US20030083295 An oligonucleotides are hybridizable with nucleic acids to inhibit the gene expression of enzyme
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083293 Drug delivery of the chromosomes comprising a heterologous DNA to selected cells and tissues; transfection, production of heterologous proteins, gene therapy, generating non-human transgenic animals
05/01/2003US20030083289 Herpesvirus vectors and their uses
05/01/2003US20030083287 ginS
05/01/2003US20030083286 Comprises penetration enhancer (fatty acid); drug delivery; increases bioavailability of oligonucleotides
05/01/2003US20030083285 Oligonucleotides; gene therapy; prophylaxis; genetic engineering
05/01/2003US20030083284 Antisense modulation of p70 S6 kinase expression
05/01/2003US20030083283 Antisense modulation of CoREST expression
05/01/2003US20030083282 Antisense modulation of stearoyl-CoA desaturase expression
05/01/2003US20030083281 Antisense modulation of PKA regulatory subunit RII beta expression
05/01/2003US20030083280 Oligonucleotides which hybridize with nucleic acids which encode said protein; gene therapy; genetic engineering; for treatment of angina and myocardial infarction
05/01/2003US20030083279 Antisense modulation of glioma-associated oncogene-3 expression
05/01/2003US20030083278 Antisense modulation of CD40 ligand expression
05/01/2003US20030083277 Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
05/01/2003US20030083276 Uses of DNA-PK
05/01/2003US20030083275 Antisense oligodeoxynucleotides regulating expression of tnf alpha
05/01/2003US20030083274 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
05/01/2003US20030083272 Sense mrna therapy
05/01/2003US20030083266 Administering N-acetyl cysteine ethyl ester for prophylaxis of stroke and trauma
05/01/2003US20030083265 TGF-beta inhibitors and methods
05/01/2003US20030083264 A peptide having the amino acid sequence proline, histidine, serine, arginine, and asparagine
05/01/2003US20030083263 Pentapeptide compounds and uses related thereto
05/01/2003US20030083262 Methods and compositions for treating inflammatory disorders
05/01/2003US20030083261 Anticancer agents
05/01/2003US20030083260 Cryptococcal mannoproteins or equivalents thereof for use in modulating neutrophil migration
05/01/2003US20030083259 Use of a peptide
05/01/2003US20030083258 Modulation of leukocyte-endothelial interactions following ischemia
05/01/2003US20030083257 Spliceable nucleotide sequence inserted into the wild-type factor viii cDNA at the original position of an intron of the genomic factor viii DNA; gene therapy; treatment of hemophilia
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083255 Peptide that inhibits stimulated endothelial cell proliferation
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083253 Polynucleotide encoding autoantigens associated with endometriosis
05/01/2003US20030083252 Neuronal uses of BMP-11
05/01/2003US20030083251 Method of use of erythropoietin to treat ischemic acute renal failure
05/01/2003US20030083250 Increasing the supply of red blood cells
05/01/2003US20030083249 Increasing the level in the cells of a potassium channel modulatory protein
05/01/2003US20030083248 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083247 Amino acid sequences for endobiotic peptides; detecting freshness and treating stress
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083244 Nucleic acid sequences that encode G-coupled protein-receptor related polypeptides
05/01/2003US20030083243 Short bioactive peptides
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030083241 Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
05/01/2003US20030083240 Bactericides
05/01/2003US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation
05/01/2003US20030083238 Cyclic hexapeptide derivatives
05/01/2003US20030083237 Anti-angiogenic peptides for cancer treatment
05/01/2003US20030083236 Myelopeptides and their therapeutic use
05/01/2003US20030083235 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents
05/01/2003US20030083233 Aqueous mixtures of oxygen-carrying and non-oxygen carrying plasma expanders; oxygen-carrying component consists of hemoglobin-based oxygen carrier, non-oxygen carrying plasma expander consists of diluent; blood substitutes
05/01/2003US20030083231 Used of androstane derivatives in treatment of conditions such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy
05/01/2003US20030082805 Methods for use of mpl ligands with primitive human stem cells
05/01/2003US20030082801 Nucleotide sequences coding membrane protein for use in the treatment of alzheimer's, pain and psychological disorders
05/01/2003US20030082800 Expression vector for use in the generation of single stranded nucleotide sequences
05/01/2003US20030082793 Method for preparation of physiologically active water-base extract and method for potentiating the activity thereof
05/01/2003US20030082786 PEG-modified uricase
05/01/2003US20030082785 24554, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor
05/01/2003US20030082784 Novel peptide having osteogenetic activity and osteogenetic accelerator containing the same
05/01/2003US20030082776 Nucleotide sequences coding enzymatic polypeptide for use in therapeutic drug design
05/01/2003US20030082770 Leukocyte adhesion inhibitor-1 polypeptide for use in the treatment of cancer
05/01/2003US20030082766 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082764 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 ... 3163